EXPANDED TRADIPITANT ACCESS FOR SINGLE PATIENT
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
I am requesting a reliance agreement with the external IRB Advarra.
The purpse is to treat a single patient with gastroparesis who has requested expanded access with tradipitant.By doing so, we will also monitor the efficacy of tradipitant in reducing individual symptoms associated with gastroparesis in this single patient and monitor the safety of tradipitant in a patient with gastroparesis by assessing adverse events in this single patient.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 848816
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com